Maraviroc intensification of cART in patients with suboptimal immunological recovery: a 48-week, placebo-controlled randomized trial

  • Steven F. L. van Lelyveld (Contributor)
  • Julia Drylewicz (Creator)
  • Maaike Krikke (Creator)
  • Ellen M. Veel (Creator)
  • Sigrid A. Otto (Creator)
  • Clemens Richter (Creator)
  • Robin Soetekouw (Creator)
  • Jan Marinus Prins (Creator)
  • Kees Brinkman (Creator)
  • Jan-Willem Mulder (Creator)
  • Frank Kroon (Creator)
  • Ananja Middel (Contributor)
  • Jori Symons (Creator)
  • Annemarie M. J. Wensing (Creator)
  • Monique Nijhuis (Creator)
  • José A. M. Borghans (Creator)
  • Kiki Tesselaar (Creator)
  • Andy I. M. Hoepelman (Creator)

Dataset

Description

File: Ki67+ CD4 and CD8 T cells. This SPSS file contains the percentage of Ki67+ CD4 and CD8 T cells at various time points during the MIRS trial. Please see the 'variable view' of the SPSS file and the 'methods' section of the paper for more informatio...
Date made available2015
PublisherFigshare

Access Dataset

Cite this